274 related articles for article (PubMed ID: 35586626)
21. Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features.
Pardi E; Borsari S; Saponaro F; Bogazzi F; Urbani C; Mariotti S; Pigliaru F; Satta C; Pani F; Materazzi G; Miccoli P; Grantaliano L; Marcocci C; Cetani F
PLoS One; 2017; 12(10):e0186485. PubMed ID: 29036195
[TBL] [Abstract][Full Text] [Related]
22. Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.
Cardoso L; Stevenson M; Thakker RV
Hum Mutat; 2017 Dec; 38(12):1621-1648. PubMed ID: 28881068
[TBL] [Abstract][Full Text] [Related]
23. Genetic defects associated with familial and sporadic hyperparathyroidism.
Hendy GN; Cole DE
Front Horm Res; 2013; 41():149-65. PubMed ID: 23652676
[TBL] [Abstract][Full Text] [Related]
24. Germline GCM2 Mutation Screening in Chinese Primary Hyperparathyroidism Patients.
Song A; Yang Y; Wang Y; Liu S; Nie M; Jiang Y; Li M; Xia W; Wang O; Xing X
Endocr Pract; 2020 Oct; 26(10):1093-1104. PubMed ID: 33471711
[TBL] [Abstract][Full Text] [Related]
25. Probability of Positive Genetic Testing Results in Patients with Family History of Primary Hyperparathyroidism.
El Lakis M; Nockel P; Gaitanidis A; Guan B; Agarwal S; Welch J; Simonds WF; Weinstein L; Marx S; Nilubol N; Patel D; Merkel R; Tirosh A; Kebebew E
J Am Coll Surg; 2018 May; 226(5):933-938. PubMed ID: 29408534
[TBL] [Abstract][Full Text] [Related]
26. A Familial Case of a Whole Germline CDC73 Deletion Discordant for Primary Hyperparathyroidism.
Hatabu N; Katori N; Sato T; Maeda N; Suzuki E; Komiyama O; Tsutsui H; Nagao T; Nakauchi-Takahashi H; Matsunaga T; Ishii T; Hasegawa T; Yamazawa K
Horm Res Paediatr; 2019; 92(1):56-63. PubMed ID: 30739106
[TBL] [Abstract][Full Text] [Related]
27. MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.
Alvelos MI; Vinagre J; Fonseca E; Barbosa E; Teixeira-Gomes J; Sobrinho-Simões M; Soares P
Eur J Endocrinol; 2013 Feb; 168(2):119-28. PubMed ID: 23093699
[TBL] [Abstract][Full Text] [Related]
28. Primary hyperparathyroidism in Chinese children and adolescents: A single-centre experience at Peking Union Medical College Hospital.
Wang W; Kong J; Nie M; Jiang Y; Li M; Xia W; Meng X; Xing X; Wang O
Clin Endocrinol (Oxf); 2017 Dec; 87(6):865-873. PubMed ID: 28833384
[TBL] [Abstract][Full Text] [Related]
29. Whole exome sequencing in familial isolated primary hyperparathyroidism.
Cetani F; Pardi E; Aretini P; Saponaro F; Borsari S; Mazoni L; Apicella M; Civita P; La Ferla M; Caligo MA; Lessi F; Mazzanti CM; Torregossa L; Oppo A; Marcocci C
J Endocrinol Invest; 2020 Feb; 43(2):231-245. PubMed ID: 31486992
[TBL] [Abstract][Full Text] [Related]
30. Novel germline variants of CDKN1B and CDKN2C identified during screening for familial primary hyperparathyroidism.
Mazarico-Altisent I; Capel I; Baena N; Bella-Cueto MR; Barcons S; Guirao X; Albert L; Cano A; Pareja R; Caixàs A; Rigla M
J Endocrinol Invest; 2023 Apr; 46(4):829-840. PubMed ID: 36334246
[TBL] [Abstract][Full Text] [Related]
31. Genetics of hereditary forms of primary hyperparathyroidism.
English KA; Lines KE; Thakker RV
Hormones (Athens); 2024 Mar; 23(1):3-14. PubMed ID: 38038882
[TBL] [Abstract][Full Text] [Related]
32. Primary Hyperparathyroidism.
Masi L
Front Horm Res; 2019; 51():1-12. PubMed ID: 30641515
[TBL] [Abstract][Full Text] [Related]
33. Novel Glial Cells Missing-2 (GCM2) variants in parathyroid disorders.
Canaff L; Guarnieri V; Kim Y; Wong BYL; Nolin-Lapalme A; Cole DEC; Minisola S; Eller-Vainicher C; Cetani F; Repaci A; Turchetti D; Corbetta S; Scillitani A; Goltzman D
Eur J Endocrinol; 2022 Feb; 186(3):351-366. PubMed ID: 35038313
[TBL] [Abstract][Full Text] [Related]
34. Familial isolated primary hyperparathyroidism/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese.
Kong J; Wang O; Nie M; Shi J; Hu Y; Jiang Y; Li M; Xia W; Meng X; Xing X
Clin Endocrinol (Oxf); 2014 Aug; 81(2):222-30. PubMed ID: 24716902
[TBL] [Abstract][Full Text] [Related]
35. A Novel Missense
Bletsis P; Metzger R; Nelson JA; Gasparini J; Alsayed M; Milas M
AACE Clin Case Rep; 2022; 8(5):194-198. PubMed ID: 36189134
[TBL] [Abstract][Full Text] [Related]
36. Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure.
El Lakis M; Nockel P; Guan B; Agarwal S; Welch J; Simonds WF; Marx S; Li Y; Nilubol N; Patel D; Yang L; Merkel R; Kebebew E
Surgery; 2018 Jan; 163(1):31-34. PubMed ID: 29108698
[TBL] [Abstract][Full Text] [Related]
37. MEN1 mutations and potentially MEN1-targeting miRNAs are responsible for menin deficiency in sporadic and MEN1 syndrome-associated primary hyperparathyroidism.
Grolmusz VK; Borka K; Kövesdi A; Németh K; Balogh K; Dékány C; Kiss A; Szentpéteri A; Sármán B; Somogyi A; Csajbók É; Valkusz Z; Tóth M; Igaz P; Rácz K; Patócs A
Virchows Arch; 2017 Sep; 471(3):401-411. PubMed ID: 28597079
[TBL] [Abstract][Full Text] [Related]
38. Molecular and Clinical Spectrum of Primary Hyperparathyroidism.
Jha S; Simonds WF
Endocr Rev; 2023 Sep; 44(5):779-818. PubMed ID: 36961765
[TBL] [Abstract][Full Text] [Related]
39. [Etiology and pathogenesis of primary hyperparathyroidism.].
Yamauchi M; Sugimoto T
Clin Calcium; 2017; 27(4):507-514. PubMed ID: 28336826
[TBL] [Abstract][Full Text] [Related]
40. Ethnicity of Patients With Germline
Guan B; Welch JM; Vemulapalli M; Li Y; Ling H; Kebebew E; Simonds WF; Marx SJ; Agarwal SK
J Endocr Soc; 2017 May; 1(5):488-499. PubMed ID: 29264504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
